Erythropoietin: A Patient Perspective

By Nancy Spaeth

Before dialysis, when I was 15, in 1963, I took first place skiing in a coed slalom race. I beat the boys. Two years later, I couldn’t walk from the lodge to the lift.

I started on dialysis in 1966. I don’t remember how many transfusions I had. It was many, at least one per month. I had to be desperate before the doctor would order blood.

I was part of the phase III clinical trial in 1987. I was on home dialysis, raising two children, alone. My hematocrit (HCT) was 11-15 percent; I couldn’t walk up the stairs. I had to crawl on my hands and knees because I was so out of breath. Once I started on the drug, I could tell there was a change within two weeks. Within 30 days, my HCT was 40! My daughter said, “All of a sudden you were up and going.” Eventually, I could run up the stairs.

I used to be asked, “What are you doing?” I answered, “What can I do? My body has me in prison.” Epo changed all of that. What a difference it made in my life!

This personal story was published in December 2008 as part of the special ASH anniversary brochure, 50 Years in Hematology: Research That Revolutionized Patient Care.

back to top

Related Items

The Story of Erythropoietin

A review of the historical advances made in the study and development of erythropoietin during the last 50 years.

Milestones in the Study and Development of Erythropoietin

These milestones supplement the article "The Story of Erythropoeitin."